Home LiteratureArticle Details
PMID: 15155773 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Chemokine receptors that mediate B cell homing to secondary lymphoid tissues are highly expressed in B cell chronic lymphocytic leukemia and non-Hodgkin lymphomas with widespread nodular dissemination.

Journal of leukocyte biology ·Vol. 76 ·No. 2 ·2004-08-00 ·Pages 462-71

López-Giral S, Quintana NE, Cabrerizo M, Alfonso-Pérez M, Sala-Valdés M, De Soria VG, Fernández-Rañada JM, Fernández-Ruiz E, Muñoz C

Abstract

B cell neoplasms present heterogeneous patterns of lymphoid organ involvement, which may be a result of the differential expression of chemokine receptors. We found that chemokine receptor (CCR)7, CXC chemokine receptor (CXCR)4, or CXCR5, the main chemokine receptors that mediate B cell entry into secondary lymphoid tissues and their homing to T cell and B cell zones therein, were highly expressed in B malignancies with widespread involvement of lymph nodes. Conversely, those pathologies with little or no nodular dissemination showed no expression to very low levels of CCR7 and CXCR5 and low to moderate levels of CXCR4. These findings provide evidence for the role of CCR7, CXCR4, and CXCR5 in determining the pattern of lymphoid organ involvement of B tumors. Functional studies were performed on B malignancies expressing different levels of CCR7, CXCR5, and CXCR4. Multiple myeloma (MM) cells did not express CCR7 nor CXCR5 and did not migrate in response to their ligands; a moderate expression of CXCR4 on MM cells was accompanied by a migratory response to its ligand, CXCL12. By contrast, cells from B cell chronic lymphocytic leukemia (B-CLL) expressed the highest levels of these chemokine receptors and efficiently migrated in response to all ligands of CCR7, CXCR4, and CXCR5. In addition, the migration index of B-CLL cells in response to both of the CCR7 ligands correlated with the presence of clinical lymphadenopathy, thus indicating that the high expression of functional chemokine receptors justifies the widespread character of B-CLL, representing a clinical target for the control of tumor cell dissemination.

MeSH Terms
ADP-ribosyl Cyclase/genetics ADP-ribosyl Cyclase 1 Antigens, CD/genetics B-Lymphocytes/physiology Cell Movement/physiology Chemotaxis/physiology Humans Leukemia, Lymphocytic, Chronic, B-Cell/genetics,metabolism Lymphoid Tissue/physiology Lymphoma, Non-Hodgkin/genetics,metabolism Membrane Glycoproteins Mutation Receptors, CCR7 Receptors, CXCR4/metabolism Receptors, CXCR5 Receptors, Chemokine/metabolism Receptors, Cytokine/metabolism
Chemicals
Antigens, CD CCR7 protein, human CXCR5 protein, human Membrane Glycoproteins Receptors, CCR7 Receptors, CXCR4 Receptors, CXCR5 Receptors, Chemokine Receptors, Cytokine ADP-ribosyl Cyclase CD38 protein, human ADP-ribosyl Cyclase 1
Authors & Affiliations
9 authors, click to expand affiliations / ORCID
López-Giral Sonia
Department of Immunology, Hospital Universitario de la Princesa, C/Diego de León, 62, 28006 Madrid, Spain.
Quintana Nuria E
Cabrerizo María
Alfonso-Pérez Manuel
Sala-Valdés Mónica
De Soria Valle Gómez Garcia
Fernández-Rañada José María
Fernández-Ruiz Elena
Muñoz Cecilia
Article Info
Journal
Journal of leukocyte biology
Abbr.
J Leukoc Biol
ISSN
0741-5400
Published
2004-08-00
Epub
2004-00-20
Pages
462-71
Language
English
Region
United States
NLM ID
8405628
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com